Literature DB >> 7049326

Immunological identification of cerebellar cell lines.

G J Giotta, J Heitzmann, M Cohn.   

Abstract

Spleen cells from BALB/c mice, previously immunized with rat cerebellar tissue, were fused to the mouse myeloma cell line SP2/0-Ag14 and the cerebellar cell type specificity of the resultant hybridomas determined. In this report we describe the specificity of one hybridoma, C4/12. Monoclonal antibodies secreted by this hybridoma recognize granule cell neurons in adult cerebellar frozen sections, and in primary cultures started from 3 to 5-day-old newborn rats. In addition, C4/12 recognizes a subclass of astrocytes when screened on primary cultures but not adult cerebellar tissue. Two temperature sensitive Rous sarcoma virus transformed cerebellar cell lines, previously shown to be either neuronal or glial, were screened for the presence of the antigen. Both cell lines are positive at the temperature permissive for transformation, whereas the glial line but not the neuronal line exhibits the antigen at the nonpermissive temperature. These results are discussed in light of the cell lines being representative of precursor cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049326     DOI: 10.1016/0165-3806(82)90043-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Voltage-gated and synaptic currents in rat Purkinje cells in dissociated cell cultures.

Authors:  T Hirano; H Ohmori
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

2.  Cerebellar granule cells in culture: monosynaptic connections with Purkinje cells and ionic currents.

Authors:  T Hirano; Y Kubo; M M Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Neuronal membrane depolarization and the control of cholinergic muscarinic receptors: selective effect on different neuronal cell types.

Authors:  R Simantov; R Levy
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.